Tesamorelin + Ipamorelin 10mg Peptide
Research Use Only
Get Notified When Available
This product is currently out of stock. Enter your email and we'll notify you the moment it's back.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
This is the standard-strength counterpart to the 20mg (10+10) presentation. Pairing a GHRH analogue with a GHRP is the conventional design for studying growth hormone pulse amplification, because the two act through separate receptors and the combination produces a larger response than either alone. Tesamorelin contributes GHRH receptor activity with the trans-3-hexenoyl modification that resists DPP-4 cleavage; ipamorelin contributes ghrelin receptor agonism with minimal cortisol or prolactin cross-activation. As with all combined vials, the fixed ratio makes this unsuitable for work that needs to vary one component independently.
Frequently Bought Together
Tesamorelin 5mg + Ipamorelin 5mg (10mg)
10mg
$139 USD
Bundle & Save
$174 USD
Save $9 USD
$239 USD
Save $24 USD
$284 USD
Save $44 USD
$319 USD
Save $64 USD
Click any product above to toggle selection
Related Peptides
Related Research News
Tesamorelin vs Ipamorelin: Evidence, Uses, Risks
This article compares tesamorelin and ipamorelin based on published human evidence, highlighting what is known about their uses and risks and where direct comparative data is missing.
CJC-1295 and Ipamorelin: Human Evidence and Limits
This reference separates what human trials, animal models, and analytical chemistry show about CJC-1295 and ipamorelin from vendor marketing, assessing the strength of the human evidence base and combination-specific safety data.
CJC-1295 and Ipamorelin Dosage: Evidence and Risks
This reference reviews the evidence on CJC-1295 and ipamorelin dosing, distinguishing what controlled studies support from what remains speculative or vendor-derived.